American Society of Hematology

SHERPA: Blue

People

  1. Schoder
    Schoder
  2. Moskowitz
    Moskowitz
  3. Noy
    Noy
  4. Zelenetz
    Zelenetz
  5. Palomba
    Palomba
  6. Horwitz
    Horwitz
  7. Hamlin
    Hamlin
  8. Yahalom
    Yahalom
  9. Kumar
    Kumar
  10. Caron
    Caron

Groups

  1. Molecular Imaging and Therapy Service (65)
  2. Radiology, Department of (65)
  3. Center for Hematologic Malignancies (55)
  4. Department of Medicine (55)
  5. Hematologic Malignancies, Division of (55)
  6. Lymphoma (55)
  7. Survivorship Research (31)
  8. Population Sciences Research Program (24)
  9. Radiation Oncology, Department of (22)
  10. Epidemiology and Biostatistics (21)
Search Within
  1. "Heiko Schoder"
Formats
  1. Meeting Abstract (46)
  2. Journal Article (19)
Groups
  1. Molecular Imaging and Therapy Service (65)
  2. Radiology, Department of (65)
  3. Center for Hematologic Malignancies (55)
  4. Department of Medicine (55)
  5. Hematologic Malignancies, Division of (55)
  6. Lymphoma (55)

More Groups

People
  1. Heiko Schoder (65)
  2. Alison Moskowitz (29)
  3. David Straus (29)
  4. Andrew Zelenetz (28)
  5. Ariela Noy (28)
  6. Maria Palomba (25)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (7)
  4. 2022 (3)
  5. 2021 (7)
  6. 2020 (5)

More Years

Publications
  1. Blood (59)
  2. Blood Advances (6)

Results (65)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Pembrolizumab for front-line treatment of extranodal NK/T-cell lymphoma
    Meeting Abstract

    Moskowitz, A.; Advani, R. H.; Ganesan, N.; Chang, T.; Hancock, H.; Davey, T.; Miller, T.; Gibaldi, A.; Smith, M.; Assini, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Brentuximab vedotin and chemotherapy in relapsed/refractory Hodgkin lymphoma: A propensity score–matched analysis
    Journal Article

    Driessen, J.; de Wit, F.; Herrera, A. F.; Zinzani, P. L.; LaCasce, A. S.; Cole, P. D.; Moskowitz, C. H.; García-Sanz, R.; Fuchs, M.; Müller, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • AHOD2131: A randomized phase 3 response-adapted trial comparing standard therapy with immuno-oncology therapy for children and adults with newly diagnosed stage I and II classic Hodgkin lymphoma
    Meeting Abstract

    Henderson, T. O.; Hu, B.; Keller, F.; Pei, Q.; Wu, Y.; Hoppe, B.; Milgrom, S.; Yao, S.; Khan, N.; Roth, L. G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of early histological transformation on survival in patients with follicular lymphoma
    Meeting Abstract

    Luttwak, E.; Qiu, A.; Okwali, M.; Rivas-Delgado, A.; Isgor, I.; Boardman, A. P.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
    Blood (2023)

    Fulltext@MSK | Save